TAZAROTENE
NDC 0713-0805, tazarotene, gel, from Cosette Pharmaceuticals, Inc..
- Product NDC
- 0713-0805
- Status
- Listed
- Labeler
- Cosette Pharmaceuticals, Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215433
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0805 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAZAROTENE.5 mg/g
Pharmacologic classes
Retinoid [EPC]; Retinoids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0713-0805-31 | 00713080531 | 1 TUBE in 1 CARTON (0713-0805-31) / 30 g in 1 TUBE |
| 0713-0805-99 | 00713080599 | 1 TUBE in 1 CARTON (0713-0805-99) / 100 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ecd718fd-c06e-4b3a-8aca-fa51e7c51a66NADAC price for package 00713080531
GET /v1/drugs/nadac/00713080531
Use it
Look up 0713-0805 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0805 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0713-0805. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.